Литература

Поставить закладку

Oliveri RS1, Wetterslev J, Gluud C. Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma. Cochrane Database Syst Rev. 2011 Mar 16;(3):CD004787. doi: 10.1002/14651858.CD004787.pub2.
Kumagi T1, Hiasa Y, Hirschfield GM. Hepatocellular carcinoma for the non-specialist. BMJ. 2009 Dec 4;339:b5039. doi: 10.1136/bmj.b5039.
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71–96.
Welzel TM, Graubard BI, et al. Population-Attributable Fractions of Risk Factors for Hepatocellular Carcinoma in the United States. The American Journal of Gastroenterology, 2013, 108(8): 1314-1321.
Deugnier YM, Guyader D, Crantock L, Lopez JM, Turlin B, Yaouanq J, et al. Primary liver cancer in genetic hemochromatosis: a clinical, pathological, and pathogenetic study of 54 cases. Gastroenterology 1993; 104: 228– 234.
Razumilava N, Gores GJ. Classification, diagnosis, and management of cholangiocarcinoma. Clin Gastroenterol Hepatol. 2013; 11:13–21.
EASL clinical practice guidelines: management of hepatocellular carcinoma. Journal of Hepatology 2018 vol. 69, 182–236.
Greten T.F., Malek N.P., Schmidt S., Arends J., Bartenstein P., Bechstein W., Bernatik T., Bitzer M., Chavan A., Dollinger M., et al. Diagnosis and therapy for hepatocellular carcinoma. Z. Gastroenterol. 2013;51:1269–1326.
Бредер В.В. Стратегия и тактика консервативного лечения гепатоцеллюлярного рака: дис. докт. мед. наук. РОНЦ им. Н.Н. Блохина, 2017.
Тихонов И.Н., Павлов Ч.С, Маевская М.В., Ивашкин В.Т. Современные подходы к скринингу и ранней диагностике гепатоцеллюлярной карциномы. Современная онкология. 2014; 03: 65-74.
Girotra M, Soota K, Dhaliwal AS, Abraham RR, Garcia-Saenz-de-Sicilia M, Tharian B. Utility of endoscopic ultrasound and endoscopy in diagnosis and management of hepatocellular carcinoma and its complications: What does endoscopic ultrasonography offer above and beyond conventional cross-sectional imaging?. World J Gastrointest Endosc. 2018;10(2):56–68.
1. .Horvat N, Monti S, Oliveira BC, Rocha CCT, Giancipoli RG, Mannelli L. State of the art in magnetic resonance imaging of hepatocellular carcinoma. Radiol Oncol. 2018;52(4):353– 364.
2. Jain D. Tissue diagnosis of hepatocellular carcinoma. J Clin Exp Hepatol. 2014;4(Suppl 3):S67–S73. doi:10.1016/j.jceh.2014.03.047.
3. Roberts, L. R., Sirlin, C. B., Zaiem, F. , Almasri, J. , Prokop, L. J., Heimbach, J. K., Murad, M. H. and Mohammed, K. (2018), Imaging for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis. Hepatology, 67: 401-421.
4. Marrero J, Kulik L,Sirlin C,Zhu A,Finn R,Abecassis M,Roberts L,Heimbach J. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.Hepatology, Vol. 68, No. 2, 2018.

Для продолжения работы требуется Registration

Предыдущая страница

Следующая страница

Литература

Table of contents